Biosimilars
Biosimilars
Supporting members taking specialty medications through our many touchpoints, expertise, data
Read the briefing →
Read the briefing →
Competition should meaningfully reduce drug costs and bring significant savings for payors
Read the briefing →
Read the briefing →
Robust pipeline is expected to bring significant savings in the autoimmune category
Read the briefing →
Read the briefing →
Drugs in the pipeline to treat ophthalmic disorders include biosimilars and novel treatments
Read the briefing →
Read the briefing →
Interpretation and analysis of marketplace trends including a robust drug development pipeline, transformative therapies and the growing importance of biosimilars; and implications for plan sponsors
Read the briefing →
Read the briefing →
CVS Health offers strategies for addressing new-to-market products to ensure access to clinically appropriate insulin or other medications.
Read the commentary →
Read the commentary →